Elite Pharmaceuticals GAAP EPS of -$0.01, revenue of $40.2M

Published 2 months ago Neutral
Elite Pharmaceuticals GAAP EPS of -$0.01, revenue of $40.2M
Auto
* Elite Pharmaceuticals press release [https://seekingalpha.com/pr/20202001-elite-pharmaceuticals-inc-reports-financial-results-for-the-first-quarter-of-fiscal-year-2026] (OTCQB:ELTP [https://seekingalpha.com/symbol/ELTP]): Q1 GAAP EPS of -$0.01.
* Revenue of $40.2M (+87.9% Y/Y).

MORE ON ELITE PHARMACEUTICALS

* Elite Pharmaceuticals, Inc. (ELTP) Q4 2025 Earnings Call Transcript [https://seekingalpha.com/article/4798720-elite-pharmaceuticals-inc-eltp-q4-2025-earnings-call-transcript]
* Financial information for Elite Pharmaceuticals [https://seekingalpha.com/symbol/ELTP/income-statement]